ITGB5 and breast carcinoma: In contrast, we were not able to find a relationship between cilengitide sensitivity and cilengitide target integrins ITGAV, ITGB3, or ITGB5, contrary to previous observations in breast cancer cell lines [16] and glioblastoma [38].